POSTER SESSION III Tuesday, March 25, 2003   —  9:30 AM - 12:00 Noon Exhibit Hall A - C GENITOURINARY PATHOLOGY 76 Prostatic Dennervation Decreases Metastasis in an Orthotopic Prostate Cancer Mouse Model (629) PJ Alphonse, N Ali, V Mouraiev, GE Ayala Baylor College of Medicine, Houston, TX 77 The Phosphorilated Form of GSK Is Involved in Prostate Cancer Progression (801) TM Wheeler, R Li, G Yang, A Frolov, T Thompson, W Harper, GE Ayala Baylor College of Medicine, Houston, TX 78 High Levels of P - Akt1 in Prostate Cancer and Normal Tissues Are Independent Predictors of Biochemical Recurrence (635) GE Ayala, R Li, G Yang, TM Wheeler, A Frolov, T Thompson, W Harper Baylor College of Medicine, Houston, TX 79 Pelvic Lymph Nodes in a Radical Prostatectomy: How Many Are There Really? (793) LD True University of Washington, Seattle, WA 80 DNA Replication Regulation Protein MCM7 and Ki67 as Markers of Proliferation in Prostate Carcinoma (751) V Padmanabhan, P Callas, TD Trainer, BG Beatty University of Vermont, Burlington, VT 81 MRI Microscopy of Ex Vivo Prostate Specimens: Radiologic and Pathologic Correlations (676) M Feldman, D Chute, M Schnall, A Madabhushi, D Metaxas, T Connick, J Tomaszewski University of Pennsylvania School Medicine, Philadelphia, PA; Rutgers Univ., New Brunswick, NJ 82 High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) in Needle Biopsy (NBx): Does Routine Use of Recuts Help in Detecting Prostatic Adenocarcinoma (PCa)? (784) P Tamboli, NA Abrahams, P Troncoso The University of Texas M. D. Anderson Cancer Center, Houston, TX 83 TMPRSS2, a Serine Protease Highly Expressed in Prostate Cancer: A Potential Target for Therapy (792) LD True, M Matsumura, S Moore, M Morrison, R Henneberg, PS Nelson Univ. of Washington, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA 84 Prostate Cancer Pathologic Parameters and Clinical Outcome: Results from the Cooperative Prostate Cancer Tissue Resource (CPCTR) (737) J Melamed, MW Datta, MJ Becich, M Bosland, R Dhir, A Kajdacsy-Balla, J Orenstein, S Silver, JJ Berman New York University School of Medicine, New York, NY; Medical College of Wisconsin, Milwaukee, WI; University of Pittsburgh, Pittsburgh, PA; George Washington University, Washington, DC; National Cancer Institute, Bethesda, MD 85 Proliferative Status of Basal Cells in Prostatic Intraepithelial Neoplasia and Adenocarcinoma. A Study by Double Immunostaining with 34$E12 and Ki67 (729) J Lloreta, T Baro, P Garcia-Moreno, E Diaz, L Pijuan, S Boluda, M Iglesias, JA Lorente, JM Corominas, A Gelabert, S Serrano Hospital del Mar-IMAS-IMIM, Universitat Pompeu Fabra, Barcelona, Spain; Autonomous University of Barcelona, Barcelona, Spain 86 "False Positive" Immunostaining for 34$E12 in Prostate Cancer: Systematic Study of the Effect of Antigen Retrieval Conditions Using High Density Tissue Microarrays (640) CJ Bennett, JL Hicks, WR Gage, AM De Marzo The Johns Hopkins University, Baltimore 87 Comparative Molecular & Morphologic Analysis of Autopsy Discovered and Clinically Evident Prostatic Carcinoma: Loss of Heterozygosity Analysis (653) C Butler, A Andea, V Pansare, X Hong, F Sarkar, D Grignon, W Sakr Harper University Hospital, Karmanos Cancer Institute & Wayne State Univ., Detroit, MI 88 Trefoil Factor 3 Overexpression in Prostatic Adenocarcinoma (672) DA Faith, J Luo, J Morgan, J Hicks, H Fedor, L Mangold, PC Walsh, AW Partin, WB Isaacs, AM De Marzo Johns Hopkins School of Medicine, Baltimore, MD 89 Correlation of Tumor Dimensions with Pathological Stage and Grade in Prostatic Carcinoma (685) B Furusato, IA Sesterhenn, CJ Davis, DG McLeod, JW Moul, FK Mostofi Armed Forces Institute of Pathology, Washington, DC; Walter Reed Army Medical Center, Washington, DC; Rockville, MD 90 KLF6 Expression in Clinically Localized and Metastatic Prostate Cancer (809) W Zhu, R Kuefer, G Narla, T Mattfeldt, JE Gschwend, SL Friedman, JA Martignetti, AM Chinnaiyan, MA Rubin Univ. of Michigan School of Medicine, Ann Arbor, MI; Ulm Univ., Ulm, Germany; Mount Sinai School of Medicine, New York, NY; Brigham and Women's Hospital, Boston, MA 91 Decreased Expression of Alpha-methylacyl-CoA Racemase / P504S in Foamy Gland Carcinoma of the Prostate (656) L Chen, Z Jiang, BA Woda, M Tretiakova, XJ Yang University of Chicago, Chicago, IL; Univ of Massachusetts Medical School, Worcester, MA 92 Expression of Estrogen Receptor Alpha and Beta, Androgen Receptor, and Glutathione-s-Transferase.B in Prostatic Adenocarcinoma (760) RD Ronchetti,CA Torres-Cabala, CA Chian-Garcia, PH Duray, J Phillips, WM Linehan National Cancer Institute, Bethesda, MD 93 Utility of Basal Cell Cocktail (p63+34$E12) in the Diagnosis of Atypical Prostatic Glandular Proliferations (772) RB Shah, LP Kunju, R Shen, M LeBlanc, M Zhou, MA Rubin University of Michigan Hospitals, Ann Arbor, MI 94 Diagnostic Utility of the Monoclonal Antibody P504S in the Work Up of Prostate Carcinoma (719) LP Kunju, MA Rubin, M LeBlanc, AM Chinnaiyan, RB Shah University of Michigan Hospitals, Ann Arbor, MI 95 Detection of High-Grade Prostatic Intraepithelial Neoplasia (PIN) by "-Methylacyl-CoA Racemase / P504S Immunohistochemistry in Previously Negative Biopsies (796) VK Vanguri, BA Woda, XJ Yang, C-L Wu, L Savas, Z Jiang University of Massachusetts Medical School, Worcester, MA; University of Chicago, Chicago, IL; Massachusetts General Hospital, Boston, MA 96 Ethnicity Based Analysis of Prostatectomy Specimens and PSA Outcomes: Results of the NCI Cooperative Prostate Cancer Tissue Resource (665) MW Datta, MJ Becich, MC Bosland, R Dhir, A Kajdacsy-Balla, J Melamed, J Orenstein, S Silver, J Berman The Cooperative Prostate Cancer Tissue Resource Medical College of Wisconsin, Milwaukee, WI; University of Pittsburgh, Pittsburgh, PA; New York University School of Medicine, New York, NY; George Washington University School of Medicine, Washington, DC; National Cancer Institute, Bethesda, MD 97 Prostatic Carcinoma Derived Osteoblast-Stimulating Activity (673) K Fan, John L. McClellan VA Hospital, Little Rock, AR